Scleritis: Differentiating infectious from non-infectious entities

被引:37
|
作者
Murthy, Somasheila, I [1 ]
Sabhapandit, Swapnali [2 ]
Balamurugan, S. [3 ]
Subramaniam, Pranesh [3 ]
Sainz-de-la-Maza, Maite [4 ]
Agarwal, Manisha [5 ]
Parvesio, Carlos [6 ]
机构
[1] LV Prasad Eye Inst, Cornea Inst, Hyderabad, India
[2] Ctr Sight, NeoRetina Eye Care Inst, Hyderabad, Telangana, India
[3] Aravind Eye Hosp, Dept Uvea, Pondicherry, India
[4] Hosp Clin Barcelona, Barcelona, Spain
[5] Dr Shroffs Char Eye Hosp, New Delhi, India
[6] Moorfields Eye Hosp, Inst Ophthalmol UCL, Biomed Res Ctr, London, England
关键词
Fungal scleritis; immune mediated scleritis; infectious scleritis; management of infectious scleritis; scleral debridement; tubercular scleritis; TUBERCULAR POSTERIOR SCLERITIS; NECROTIZING SCLERITIS; CLINICAL-FEATURES; VISUAL OUTCOMES; MANAGEMENT; SCLEROKERATITIS; EPIDEMIOLOGY; EPISCLERITIS; COMPLICATION; EXPERIENCE;
D O I
10.4103/ijo.IJO_2032_20
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Scleritis is a rare painful ocular disorder, associated with severe ocular pain and tissue destruction. Although a majority of these cases are immune mediated and at least half of these are associated with systemic immune-mediated diseases, a smaller minority are due to infections of the sclera. The two conditions closely mimic each other, and a thorough knowledge of the subtle differences is necessary in order to reach a timely diagnosis. Diagnostic delay can lead to a poor outcome both due to the destruction caused by the uncontrolled infection and also due to propagation of the infection with the use of corticosteroids which may have been started for presumed immune mediated scleritis. In this review, we present the clinical features, etiological agents, and the differentiating features between immune and infectious scleritis. We also present diagnostic and management guidelines for managing scleral infection.
引用
收藏
页码:1818 / 1828
页数:11
相关论文
共 50 条
  • [21] Adalimumab in the treatment of refractory non-infectious scleritis: 6-month outcomes
    Emilia Bober
    Kristina Frain
    Majid Fotuhi
    Jonathan Virgo
    Edward Hindle
    Jianfei Ma
    Joshua Luis
    Peter Addison
    Narciss Okhravi
    William Tucker
    Mark Westcott
    Carlos Pavesio
    Richard Lee
    Ian Yeung
    Eye, 2024, 38 : 628 - 630
  • [22] Adalimumab in the treatment of refractory non-infectious scleritis: 6-month outcomes
    Yeung, Ian
    Bober, Emilia
    Frain, Kristina
    Fotuhi, Majid
    Virgo, Jonathan
    Hindle, Edward
    Ma, Jianfei
    Addison, Peter
    Okhravi, Narciss
    Tucker, William
    Westcott, Mark
    Pavesio, Carlos
    Lee, Richard
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [23] Adalimumab in the treatment of refractory non-infectious scleritis: 6-month outcomes
    Bober, Emilia
    Frain, Kristina
    Fotuhi, Majid
    Virgo, Jonathan
    Hindle, Edward
    Ma, Jianfei
    Luis, Joshua
    Addison, Peter
    Okhravi, Narciss
    Tucker, William
    Westcott, Mark
    Pavesio, Carlos
    Lee, Richard
    Yeung, Ian
    EYE, 2024, 38 (03) : 628 - 630
  • [24] Biologic Therapies and Small Molecules for the Management of Non-Infectious Scleritis: A Narrative Review
    Jurgen Sota
    Matteo-Maria Girolamo
    Bruno Frediani
    Gian Marco Tosi
    Luca Cantarini
    Claudia Fabiani
    Ophthalmology and Therapy, 2021, 10 : 777 - 813
  • [25] Effectiveness of pharmacological agents for the treatment of non-infectious scleritis: a systematic review protocol
    Ingaralingam, Sathana
    Rauz, Saaeha
    Murray, Philip I.
    Barry, Robert J.
    SYSTEMATIC REVIEWS, 2020, 9 (01)
  • [26] ADALIMUMAB IN THE TREATMENT OF REFRACTORY NON-INFECTIOUS SCLERITIS: 18-MONTH OUTCOMES
    Bober, Emilia
    Fotuhi, Majid
    Frain, Kristina
    Luis, Joshua
    Virgo, Jonathan
    Hindle, Edward
    Diwany, Safiyya
    Ma, Jianfei
    Westcott, Mark
    Rees, Angela
    Tucker, William
    Addison, Peter
    Pavesio, Carlos
    Okhravi, Narciss
    Yeung, Ian
    EYE, 2024, 38 : 196 - 197
  • [27] NON-INFECTIOUS GRANULOMA
    FETT, HC
    POOL, CC
    AMERICAN JOURNAL OF SURGERY, 1951, 81 (02): : 243 - 245
  • [28] Infectious versus non-infectious loosening of implants: activation of T lymphocytes differentiates between the two entities
    Ulrike Dapunt
    Thomas Giese
    Birgit Prior
    Matthias M. Gaida
    G. Maria Hänsch
    International Orthopaedics, 2014, 38 : 1291 - 1296
  • [29] Infectious versus non-infectious loosening of implants: activation of T lymphocytes differentiates between the two entities
    Dapunt, Ulrike
    Giese, Thomas
    Prior, Birgit
    Gaida, Matthias M.
    Haensch, G. Maria
    INTERNATIONAL ORTHOPAEDICS, 2014, 38 (06) : 1291 - 1296
  • [30] Alive but non-infectious
    Dixon, B
    LANCET INFECTIOUS DISEASES, 2002, 2 (12): : 774 - 774